Developing blood-based diagnostic tests for the early detection of neurological disorders like Alzheimer's disease.
T-NeuroDx has raised $500K in total funding. The most recent round was Grant. The last funding was announced in August 2025.
T-NeuroDx's investors include National Institutes of Health.
T-NeuroDx is headquartered in Albuquerque, United States.
Developing blood-based diagnostic tests for the early detection of neurological disorders like Alzheimer's disease.
T-NeuroDx is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"T-NeuroDx — Funding & Investors." VCBacked, August 13, 2025, https://www.vcbacked.co/company/t-neurodx. Accessed August 16, 2026.
VCBacked. (2025). T-NeuroDx — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/t-neurodx
{{cite web |title=T-NeuroDx — Funding & Investors |url=https://www.vcbacked.co/company/t-neurodx |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated